Literature DB >> 30709740

Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis.

Jing Zhou1, Hui Peng2, Kun Li3, Kun Qu3, Baohui Wang1, Yuzhang Wu4, Lilin Ye4, Zhongjun Dong5, Haiming Wei1, Rui Sun1, Zhigang Tian6.   

Abstract

The tolerogenic microenvironment of the liver is associated with impaired hepatic T cell function. Here, we examined the contribution of liver-resident natural killer (LrNK) cells, a prominent hepatic NK cell compartment, to T cell antiviral responses in the liver. The number of virus-specific T cells increased in LrNK-cell-deficient mice during both acute and chronic lymphocytic choriomeningitis virus infection. Upon infection with adenovirus, hepatic T cells from these mice produced more cytokines, which was accompanied by reduced viral loads. Transfer of LrNK cells into LrNK-cell-deficient or wild-type mice inhibited hepatic T cell function, resulting in impaired viral clearance, whereas transfer of conventional NK cells promoted T cell antiviral responses. LrNK-cell-mediated inhibition of T cell function was dependent on the PD-1-PD-L1 axis. Our findings reveal a role for LrNK cells in the regulation of T cell immunity and provide insight into the mechanisms of immune tolerance in the liver.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PD-L1; antiviral responses; conventional NK cells; hepatic T cells; liver-resident NK cells

Mesh:

Substances:

Year:  2019        PMID: 30709740     DOI: 10.1016/j.immuni.2018.12.024

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  52 in total

1.  The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.

Authors:  Wenjuan Dong; Xiaojin Wu; Shoubao Ma; Yufeng Wang; Ansel P Nalin; Zheng Zhu; Jianying Zhang; Don M Benson; Kai He; Michael A Caligiuri; Jianhua Yu
Journal:  Cancer Discov       Date:  2019-07-24       Impact factor: 39.397

2.  Inflammation-Induced Lactate Leads to Rapid Loss of Hepatic Tissue-Resident NK Cells.

Authors:  Garvin Dodard; Angela Tata; Timothy K Erick; Diego Jaime; S M Shahjahan Miah; Linda Quatrini; Bertrand Escalière; Sophie Ugolini; Eric Vivier; Laurent Brossay
Journal:  Cell Rep       Date:  2020-07-07       Impact factor: 9.423

3.  Ly49E separates liver ILC1s into embryo-derived and postnatal subsets with different functions.

Authors:  Yawen Chen; Xianwei Wang; Xiaolei Hao; Bin Li; Wanyin Tao; Shu Zhu; Kun Qu; Haiming Wei; Rui Sun; Hui Peng; Zhigang Tian
Journal:  J Exp Med       Date:  2022-03-29       Impact factor: 14.307

Review 4.  True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity.

Authors:  Luke Riggan; Aharon G Freud; Timothy E O'Sullivan
Journal:  Trends Immunol       Date:  2019-09-06       Impact factor: 16.687

5.  Minimal PD-1 expression in mouse and human NK cells under diverse conditions.

Authors:  Sean J Judge; Cordelia Dunai; Ethan G Aguilar; Sarah C Vick; Ian R Sturgill; Lam T Khuat; Kevin M Stoffel; Jonathan Van Dyke; Dan L Longo; Morgan A Darrow; Stephen K Anderson; Bruce R Blazar; Arta M Monjazeb; Jonathan S Serody; Robert J Canter; William J Murphy
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

6.  Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells.

Authors:  Yihe Yan; Leting Zheng; Qiang Du; Xiao Cui; Kun Dong; Yarong Guo; David A Geller
Journal:  Br J Cancer       Date:  2021-03-26       Impact factor: 7.640

Review 7.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

8.  Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis.

Authors:  Laura Ducimetière; Giulia Lucchiari; Gioana Litscher; Marc Nater; Laura Heeb; Nicolás Gonzalo Nuñez; Laura Wyss; Dominik Burri; Marijne Vermeer; Julia Gschwend; Andreas E Moor; Burkhard Becher; Maries van den Broek; Sonia Tugues
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

9.  Efficacy and Treatment Strategies in Advanced Cancers with Liver Metastasis Receiving Atezolizumab Therapy.

Authors:  Wen-Jing Yin; Si-Cong Ma; Zhong-Yi Dong; Meng Xu; Wu Mao
Journal:  Cancer Manag Res       Date:  2021-06-08       Impact factor: 3.989

Review 10.  Natural killer cells in antiviral immunity.

Authors:  Niklas K Björkström; Benedikt Strunz; Hans-Gustaf Ljunggren
Journal:  Nat Rev Immunol       Date:  2021-06-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.